Management of complicated facial hemangiomas with beta-blocker (propranolol) therapy.
Arneja
Jugpal S
JS
Vancouver, British Columbia, Canada; and Detroit, Mich. From the Division of Plastic Surgery/Vascular Anomalies Clinic, British Columbia Children's Hospital and the University of British Columbia, and the Vascular Anomalies Clinic, Children's Hospital of Michigan.
Pappas
Peggy N
PN
Shwayder
Tor A
TA
Cullen
Marc L
ML
Becker
Cristie J
CJ
Hamzavi
Fasahat H
FH
Roarty
John D
JD
Madgy
David N
DN
Baker
John D
JD
D000319:Adrenergic beta-Antagonists / Q000627:therapeutic use*; D005153:Facial Neoplasms / Q000150:complications / Q000188:drug therapy*; D005260:Female; D006391:Hemangioma / Q000150:complications / Q000188:drug therapy*; D006801:Humans; D007223:Infant; D011433:Propranolol / Q000627:therapeutic use*
D000319:Adrenergic beta-Antagonists; D011433:Propranolol
Drolet BA, Esterly NB, Frieden IJ. Hemangiomas in children. N Engl J Med. 1999;341:173–181.
Arneja JS, Gosain AK. Vascular malformations. Plast Reconstr Surg. 2008;121:195e–206e.
Beck DO, Gosain AK. The presentation and management of hemangiomas. Plast Reconstr Surg. 2009;123:181e–191e.
Lande RG, Crawford PM, Ramsey BJ. Psychosocial impact of vascular birthmarks. Facial Plast Surg Clin North Am. 2001;9:561–567.
Léauté-Labrèze C, Dumas de la Roque E, Hubiche T, Boralevi F, Thambo JE, Taïeb A. Propranolol for severe hemangiomas of infancy. N Engl J Med. 2008;358:2649–2651.
Sans V, Dumas de la Roque E, Berge J, et al. Propranolol for severe infantile hemangiomas: Follow-up report. Pediatrics 2009;124:e423.
Buckmiller L, Dyamenahalli U, Richter GT. Propranolol for airway hemangiomas: Case report of novel treatment. Laryngoscope 2009;119:2051–2054.
Denoyelle F, Leboulanger N, Enjolras O, Harris R, Roger G, Garabedian EN. Role of propranolol in the therapeutic strategy of infantile laryngotracheal hemangioma. Int J Pediatr Otorhinolaryngol. 2009;73:1168–1172.
Persad S, Rupp H, Jindal R, Arneja J, Dhalla NS. Modification of cardiac beta-adrenoceptor mechanisms by H2O2. Am J Physiol. 1998;274:H416–H423.
Lawley LP, Siegfried E, Todd JL. Propranolol treatment for hemangioma of infancy: Risks and recommendations. Pediatr Dermatol. 2009;26:610–614.
Siegfried EC, Keenan WJ, Al-Jureidini S. More on propranolol for hemangiomas of infancy. N Engl J Med. 2008;359:2846.
Buckmiller LM. Propranolol treatment for infantile hemangiomas. Curr Opin Otolaryngol Head Neck Surg. 2009;17:458–459.
Garlichs CD, Zhang H, Mügge A, Daniel WG. Beta-blockers reduce the release and synthesis of endothelin-1 in human endothelial cells. Eur J Clin Invest. 1999;29:12–16.
Annabi B, Lachambre MP, Plouffe K, Moumdjian R, Béliveau R. Propranolol adrenergic blockade inhibits human brain endothelial cells tubulogenesis and matrix metalloproteinase-9 secretion. Pharmacol Res. 2009;60:438–445.
Romana-Souza B, Nascimento AP, Monte-Alto-Costa A. Low-dose propranolol improves cutaneous wound healing of burn-injured rats. Plast Reconstr Surg. 2008;122:1690–1699.
Arneja JS, Mulliken JB. Resection of amblyogenic periocular hemangiomas: Indications and outcomes. Plast Reconstr Surg. 2010;125:274–281.